Pregled bibliografske jedinice broj: 1281007
Liver and Nonliver-Related Outcomes at 2 Years Are Not Influenced by the Results of the FIB-4 Test and Liver Elastography in a Real-Life Cohort of Patients with Type 2 Diabetes
Liver and Nonliver-Related Outcomes at 2 Years Are Not Influenced by the Results of the FIB-4 Test and Liver Elastography in a Real-Life Cohort of Patients with Type 2 Diabetes // Canadian journal of gastroenterology & hepatology, 2021 (2021), 5582813, 9 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1281007 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Liver and Nonliver-Related Outcomes at 2 Years Are
Not Influenced by the Results of the FIB-4 Test
and Liver Elastography in a Real-Life Cohort of
Patients with Type 2 Diabetes
Autori
Grgurevic, Ivica ; Salkic, Nermin ; Mustapic, Sanda ; Bokun, Tomislav ; Podrug, Kristian ; Marusic, Srecko ; Rahelic, Dario ; Matic, Tomas ; Skurla, Viktoria ; Mikolasevic, Ivana
Izvornik
Canadian journal of gastroenterology & hepatology (2291-2789) 2021
(2021);
5582813, 9
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
nonalcoholic fatty liver disease ; type 2 diabetes
Sažetak
Aims To investigate morbidity and mortality in a real- life cohort of patients with type 2 diabetes (T2D) in relation to prevalence and severity of nonalcoholic fatty liver disease (NAFLD). Methods Patients with T2D were referred for assessment of liver fibrosis by the FIB-4 test and liver stiffness measurement (LSM) by vibration- controlled transient elastography (VCTE). Liver steatosis was quantified by the controlled attenuation parameter (CAP). These patients were followed until death or censored date. Results Among 454 patients (52% males, mean age 62.5 years, BMI 30.9 kg/m2), 82.6% was overweight, 77.8% had fatty liver, and 9.9% and 3.1% had LSM and FIB-4 values suggestive of advanced fibrosis, respectively. During the follow-up period of median 2 years, 106 (23%) patients experienced adverse event (11% cardiovascular) and 17 (3.7%) died, whereas no liver-related morbidity or mortality was observed. Independent predictors of adverse outcomes were age and higher platelet count, while FIB-4, LSM, and CAP were not. Conclusion In a cohort of T2D patients, no liver-related morbidity or mortality occurred during 2 years. Our patients probably have low real prevalence of advanced fibrosis which is likely overestimated by LSM ≥ 9.6 kPa. Liver fibrosis may be safely reassessed in the 2 years interval in noncirrhotic patients with T2D.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Klinička bolnica "Merkur",
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava",
Medicinski fakultet, Osijek
Profili:
Ivana Mikolašević
(autor)
Srećko Marušić
(autor)
Tomislav Bokun
(autor)
Ivica Grgurević
(autor)
Dario Rahelić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE